Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DBV712 Viaskin®
- Development stage
- Phase 3
- Lead developer
- DBV Technologies
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Epicutaneous, Transdermal
01
Overview
DBV712 Viaskin® is an epicutaneous immunotherapy (EPIT) patch developed by DBV Technologies for the treatment of peanut allergy. This patch-based system delivers microgram amounts of peanut protein (allergen) to the intact non-vascularized epidermis. The mechanism involves the absorption of the allergen by antigen-presenting cells, such as Langerhans cells, which then migrate to lymph nodes. In the lymph nodes, these cells induce specific T-regulatory cells that work to suppress the allergic response, thereby desensitizing the individual to peanuts and reducing the severity of allergic reactions upon exposure. The product is primarily indicated for peanut allergy in children.
- Brand names
- Viaskin PeanutViaskin®
- Other names
- peanut patch
Beyond the preview
Go deeper on DBV712 Viaskin®.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DBV712 Viaskin®.